A Clinical Study of MK-4482 in Chinese Healthy Male Participants (MK-4482-009)
Status:
COMPLETED
Trial end date:
2023-08-05
Target enrollment:
Participant gender:
Summary
The goal of the study is to learn what happens to MK-4482 after single and multiple doses in healthy Chinese participants over time. Researchers also want to learn about the safety of MK-4482, including how well people tolerate it.